Actualités

The tech company's latest numbers showed significant improvements in revenue, gross margin, and net income.

Strategy (Nasdaq: MSTR) has launched a public tool that shows investors exactly how well its Bitcoin holdings cover the money it owes, a move toward greater transparency about the risks on its balance sheet. Executive chairman Michael Saylor announced the Bitcoin Credit Model on Aug. 12. Strategy ...

Mundy's sale was executed under a pre-arranged Rule 10b5-1 trading plan, while maintaining a $4 million position.

Tesla, led by Elon Musk, is looking to build a massive solar panel factory just outside Houston, Texas, according to documents filed with the state.

IBM (NYSE:IBM) just signed a $240 million deal with Together AI to build an Nvidia (NASDAQ:NVDA)-powered AI inference cluster on IBM Cloud, announced August 11. Together AI’s chief revenue officer Kai Mak says demand is so strong the cluster will sell out two to three months before it even goes live. That kind of confidence […]

Paramount in recent months has discussed creating an editorial board for CNN and other safeguards to ease concerns over its news operation’s independence, according to people familiar with the situation. Paramount, which owns CBS News, has agreed to buy CNN parent Warner Bros. Discovery for $81 billion. The internal discussions about establishing an oversight committee for news have come up as the company has planned for the deal’s closing, the people said.

The investor made famous by The Big Short is doubling down on his bets against some of the biggest names in AI.

Software platforms faced selling pressure due to concerns that generative AI tools would replace traditional software architectures. However, Shopify Inc. (NASDAQ:SHOP) broke away from sector headwinds after second-quarter financial results showed AI tools driving business formation rather than displacing its e-commerce infrastructure. Because Shopify serves small and medium-sized businesses requiring turnkey checkout, payment processing, and […]

MongoDB is drawing significant analyst attention as its Q2 results are set to reveal if the company can maintain its growth momentum.

Nate Gatten’s appointment comes as Apple navigates tariffs, White House relations and a broader shake-up across its senior leadership ranks.

Norway’s fund also publicly declared owning a 0.05% stake in SpaceX.

Elon Musk just declared his latest AI model objectively number one in intelligence, speed, and cost, and the timing could not be worse for two companies that Microsoft is betting billions on.

The band the options market prices for the next ten months runs from just under the low this stock has set over the past year to a level far above today's price, and the volatility behind it is close to what the stock has actually been doing.

A Washington tax proposal targeting inflation adjustments on capital gains could reshape what Elon Musk eventually owes on his massive Tesla stake, but the math reveals a far messier picture than the headlines suggest.

Bristol Myers growth portfolio now accounts for 56% of revenues, led by key drugs, including Opdivo Qvantig, Reblozyl and Breyanzi, helping offset generic erosion.

DexCom's broader CGM coverage, G7 15 Day rollout and rising margins support growth, but premium valuation, competition and litigation temper upside.

<p>Goldman Sachs will acquire NEOS Investments in a deal worth up to $2.25 billion, adding $30 billion in options-based income ETFs and vaulting Goldman Sachs Asset Management into the ranks of top-eight active ETF issuers.</p>

Missile shortages and a Pentagon production push could boost Lockheed Martin, RTX and defense ETFs as replenishment drives new orders.

Checks are being mailed from Grubhub's $23.8 million fine from the FTC after it settled allegations over its business practices.

DXCM's 2026 rebound is backed by stronger growth, G7 15 Day adoption and broader CGM access, but competition and reimbursement remain key risks.

By Amina Niasse NEW YORK, Aug 12 (Reuters) - Hims & Hers Health plans to offer some legally available peptides in 2026, but investors and analysts who spoke to Reuters after the telehealth company's

AI infrastructure stocks rose on Wednesday after strong quarterly financial reports from AI server hardware maker Super Micro Computer Inc. (NASDAQ:SMCI) and neocloud providers CoreWeave, Inc. (NASDAQ:CRWV) and Nebius Group NV (NASDAQ:NBIS). Big Tech companies have already signaled that spending on AI would not slow down. The combined outlays are set to surpass $730 billion […]

ISRG's US procedure growth slows in Q2, but ACA-related care deferrals may prove temporary as underlying demand and da Vinci 5 adoption remain strong.

UnitedHealth's lower medical costs are fueling an earnings recovery, but rising commercial costs and 2027 pricing decisions could test its durability.

DexCom's 52.5% three-month rally is backed by earnings growth and margin gains, but premium valuation, competition and litigation raise the bar.

DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability, while FX and transition costs remain key tests.

The memory maker's revenues continue to skyrocket thanks to a worldwide shortage that has catapulted memory prices higher.

Former Wendy’s chairman Nelson Peltz is reportedly putting an offer together to buy Wendy’s, according to Reuters and The Financial Times. The billionaire’s Trian Fund Management is working with a group that includes BlueFive Capital and Flynn Group, the world’s largest franchisee organization. The latter became a franchisee of Wendy’s in 2021 after it purchased […]

Rocket Lab is growing fast, with a record backlog and rising revenue, but a possible Neutron delay is weighing on RKLB stock. So, where does the stock go from here?

Two healthcare giants, two very different dividend bets: one built on six decades of unbroken raises and a fortress balance sheet, the other dangling a fatter yield while racing to outrun its own blockbuster's collapse. Knowing which risk you are actually buying changes everything.